caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1669730917

Tina Mcintire-StrainNP

PRACTICECOVENANT MEDICAL GROUPSee all providers at this practice →
Nurse PractitionerSaginaw, MII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
141
Unique beneficiaries
—
Total services
144
Distinct HCPCS
4
Medicare payment
$5K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 5,391 Nurse Practitioner providers in MI — above median (cohort median 188).
REFERRAL NETWORK

Where Tina Mcintire-Strain's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
STRUBLE, RUSSELL121490
James Finch
Diagnostic Radiology · Bay City, MI
1326
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
240
Beneficiaries
—
Total drug cost
$724
Distinct drugs
7
Brand share
5.8%
Top prescribed drugs
Prednisone90 claims
Cephalexin52 claims
Fluconazole31 claims
Doxycycline Hyclate24 claims
Amoxicillin16 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.